Burek Julie
SEC CIK 1894915 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | VP, Fin | 52.5K | — | $35.5K | 7 | 2021-11-26 | 2022-03-21 |
Most active insiders at VYGR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| 2 | Swartz Robin | COO, CBO | — | $55.3K |
| 3 | Jorgensen Nathan D. | CFO | — | $54.2K |
| 4 | Carter Todd Alfred | CSO | — | $40.6K |
| 5 | Shiferman Gregory L. | SVP, GC | — | — |
| 6 | Ferguson Toby | Chief Medical Off | — | — |
Burek Julie made no open-market trades at VYGR in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-23 | 2022-03-21 | VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Fin | S - Sale | $8.29 | -2,649 | 52.5K | -5% | -$22.0K |
| 2022-02-22 | 2022-02-17 | VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Fin | S - Sale | $3.55 | -789 | 55.1K | -1% | -$2,801 | |
| 2022-02-15 | 2022-02-11 | VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Fin | S - Sale | $3.36 | -361 | 55.9K | -0.6% | -$1,213 | |
| D | 2022-01-18 | 2022-01-13 | VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Fin | A - Grant | $0.00 | +10.0K | 56.3K | +22% | $0 |
| M | 2022-01-14 | 2022-01-03+ | VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Fin | S - Sale | $2.85 | -3,328 | 46.3K | -7% | -$9,479 |
| 2022-01-14 | 2021-12-31 | VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Fin | A - Grant | $2.30 | +3,063 | 49.6K | +7% | +$7,045 | |
| D | 2021-11-30 | 2021-11-26 | VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Fin | A - Grant | $0.00 | +13.5K | 46.5K | +41% | $0 |
Purchase Sale Sale after option exercise All abbreviations